Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

No reported Other Income / Expenses figures are available to summarize.

Other Income / Expenses history

Currency unavailable · from the income statement

No Other Income / Expenses data reported for this period type.

Other Income / Expenses vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Other Income / Expenses for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$4.63M USD+149.5%+268.2%—
TNYATenaya Therapeutics, Inc.LTM Mar 2026$2.85M USD-27.9%+11.8%1268.0%
RNAAtrium Therapeutics, Inc.FY2025-$12K USD——0.1%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026-$15.1M USD-313.4%—212.0%
CYTKCytokinetics, IncorporatedLTM Jun 2026-$189.38M USD-219.2%—266.9%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-123.6%+140.0%239.4%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.